Pricing

Laverock Therapeutics

0 followers

‌

Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Industries

Biotechnology, Therapeutics

Employees

11-50

Links

Org chart

David Venables

CEO

David Venables

Collapse

John Brown

Non Executive Director

Sandy McDougall

Chief Financial Officer

Tim Allsopp

CTO

Tom Payne

Chief Operating Officer

Vlad Seitan

Chief Scientific Officer

Teams

Research and Development

7 members

Leadership Team

6 members

Similar companies

Immunome

2 followers

Amgen

208 followers

Elicio Therapeutics

1 follower

Nunzio Marc DeSantis Architects

1 follower

Artiva Biotherapeutics

1 follower

Lucid Management and Capital Partners LP

1 follower

HCLTech

175 followers

Capricor Therapeutics

1 follower

Teleperformance

64 followers

Merkle

63 followers

Wetalkie

3 followers

Explore companies